Compare Kenvue Inc. Common Stock (KVUE) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B). The key difference: Kenvue Inc. Common Stock is far larger — about 19.6× Nuvation Bio Inc. Class A Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| KVUE | NUVB | |
|---|---|---|
Market Cap | $34.06B | $1.74B |
Volume | 23,267,228 | 9,289,619 |
Sector | Consumer Staples | Health |
52-Week High | $19.83 | $9.54 |
52-Week Low | $14.11 | $3.41 |
Enterprise Value | $41.56B | $1.33B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 1 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
